Journal article
Triple Therapy for the Management of COPD: A Review
Abstract
Triple therapy for COPD consists of a long-acting anti-cholinergic bronchodilator, a long-acting beta-agonist bronchodilator, and an inhaled corticosteroid. Guidelines from the Canadian Thoracic Society advocate triple therapy for some patients with moderate-to-severe COPD. The objective of this review was to evaluate the evidence based clinical efficacy of triple therapy compared to dual bronchodilator therapy (long-acting anti-cholinergic …
Authors
Gaebel K; McIvor RA; Xie F; Blackhouse G; Robertson D; Assasi N; Hernandez P; Goeree R
Journal
COPD Journal of Chronic Obstructive Pulmonary Disease, Vol. 8, No. 3, pp. 206–243
Publisher
Taylor & Francis
Publication Date
May 27, 2011
DOI
10.3109/15412555.2011.560131
ISSN
1541-2555